Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester.
Antiretroviral (ARV) therapy in HIV patients can cause hyperlipidaemia, glucose intolerance and insulin resistance, which increase the risk of cardiovascular disease (CVD). An audit carried out in Manchester found that CVD risk factors were common among HIV patients receiving ARVs; however, the management of risk factors was not satisfactory. Adopting a formal system to identify and manage CVD risk factors as well as appropriate referral for specialist management of complications of ARV therapy would improve patient care.
Mallewa
J E
JE
Department of Infectious Diseases, North Manchester General Hospital, Crumpsall, Manchester M8 5RB, UK. janemallewa@yahoo.com
Higgins
S P
SP
Garbett
S
S
Saxena
N
N
Vilar
F J
FJ
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D001786:Blood Glucose; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D019983:Guideline Adherence; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced / Q000150:complications / Q000453:epidemiology; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000150:complications / Q000453:epidemiology; D008485:Medical Audit; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D006113:United Kingdom
D019380:Anti-HIV Agents; D001786:Blood Glucose